Simulation-based adjustment after exploratory biomarker subgroup selection in phase II

As part of the evaluation of phase II trials, it is common practice to perform exploratory subgroup analyses with the aim of identifying patient populations with a beneficial treatment effect. When investigating targeted therapies, these subgroups are typically defined by biomarkers. Promising resul...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Götte, Heiko (VerfasserIn) , Kirchner, Marietta (VerfasserIn) , Kieser, Meinhard (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 24 April 2017
In: Statistics in medicine
Year: 2017, Jahrgang: 36, Heft: 15, Pages: 2378-2390
ISSN:1097-0258
DOI:10.1002/sim.7294
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1002/sim.7294
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/sim.7294
Volltext
Verfasserangaben:Heiko Götte, Marietta Kirchner, Martin Oliver Sailer, Meinhard Kieser

MARC

LEADER 00000caa a2200000 c 4500
001 1580942814
003 DE-627
005 20220815010644.0
007 cr uuu---uuuuu
008 180913s2017 xx |||||o 00| ||eng c
024 7 |a 10.1002/sim.7294  |2 doi 
035 |a (DE-627)1580942814 
035 |a (DE-576)510942814 
035 |a (DE-599)BSZ510942814 
035 |a (OCoLC)1341018626 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Götte, Heiko  |d 1977-  |e VerfasserIn  |0 (DE-588)134019911  |0 (DE-627)559480601  |0 (DE-576)300258577  |4 aut 
245 1 0 |a Simulation-based adjustment after exploratory biomarker subgroup selection in phase II  |c Heiko Götte, Marietta Kirchner, Martin Oliver Sailer, Meinhard Kieser 
264 1 |c 24 April 2017 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 13.09.2018 
520 |a As part of the evaluation of phase II trials, it is common practice to perform exploratory subgroup analyses with the aim of identifying patient populations with a beneficial treatment effect. When investigating targeted therapies, these subgroups are typically defined by biomarkers. Promising results may lead to the decision to select the respective subgroup as the target population for a subsequent phase III trial. However, a selection based on a large observed treatment effect may potentially induce an upwards-bias leading to over-optimistic expectations on the success probability of the phase III trial. We describe how Approximate Bayesian Computation techniques can be used to derive a simulation-based bias adjustment method in this situation. Recommendations for the implementation of the approach are given. Simulation studies show that the proposed method reduces bias substantially compared with the maximum likelihood estimator. The procedure is illustrated with data from an oncology trial. Copyright © 2017 John Wiley & Sons, Ltd. 
650 4 |a probability of success 
650 4 |a ABC 
650 4 |a bias adjustment 
650 4 |a posterior approximation 
650 4 |a subgroup selection 
700 1 |a Kirchner, Marietta  |d 1985-  |e VerfasserIn  |0 (DE-588)1045114057  |0 (DE-627)773810285  |0 (DE-576)398478910  |4 aut 
700 1 |a Kieser, Meinhard  |d 1960-  |e VerfasserIn  |0 (DE-588)103276547X  |0 (DE-627)739277766  |0 (DE-576)168963825  |4 aut 
773 0 8 |i Enthalten in  |t Statistics in medicine  |d Chichester [u.a.] : Wiley, 1982  |g 36(2017), 15, Seite 2378-2390  |h Online-Ressource  |w (DE-627)30246719X  |w (DE-600)1491221-1  |w (DE-576)079719686  |x 1097-0258  |7 nnas  |a Simulation-based adjustment after exploratory biomarker subgroup selection in phase II 
773 1 8 |g volume:36  |g year:2017  |g number:15  |g pages:2378-2390  |g extent:13  |a Simulation-based adjustment after exploratory biomarker subgroup selection in phase II 
856 4 0 |u http://dx.doi.org/10.1002/sim.7294  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/sim.7294  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180913 
993 |a Article 
994 |a 2017 
998 |g 103276547X  |a Kieser, Meinhard  |m 103276547X:Kieser, Meinhard  |d 910000  |d 999701  |e 910000PK103276547X  |e 999701PK103276547X  |k 0/910000/  |k 1/910000/999701/  |p 3 
998 |g 1045114057  |a Kirchner, Marietta  |m 1045114057:Kirchner, Marietta  |d 910000  |d 999701  |e 910000PK1045114057  |e 999701PK1045114057  |k 0/910000/  |k 1/910000/999701/  |p 1  |x j 
999 |a KXP-PPN1580942814  |e 3025487402 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"24 April 2017"}],"note":["Gesehen am 13.09.2018"],"title":[{"title":"Simulation-based adjustment after exploratory biomarker subgroup selection in phase II","title_sort":"Simulation-based adjustment after exploratory biomarker subgroup selection in phase II"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"role":"aut","given":"Heiko","family":"Götte","display":"Götte, Heiko"},{"display":"Kirchner, Marietta","family":"Kirchner","given":"Marietta","role":"aut"},{"display":"Kieser, Meinhard","family":"Kieser","given":"Meinhard","role":"aut"}],"relHost":[{"pubHistory":["1.1982 -"],"recId":"30246719X","physDesc":[{"extent":"Online-Ressource"}],"id":{"doi":["10.1002/(ISSN)1097-0258"],"zdb":["1491221-1"],"issn":["1097-0258"],"eki":["30246719X"]},"disp":"Simulation-based adjustment after exploratory biomarker subgroup selection in phase IIStatistics in medicine","language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 28.02.08"],"origin":[{"dateIssuedKey":"1982","publisher":"Wiley","dateIssuedDisp":"1982-","publisherPlace":"Chichester [u.a.]"}],"title":[{"title":"Statistics in medicine","title_sort":"Statistics in medicine"}],"part":{"volume":"36","extent":"13","pages":"2378-2390","text":"36(2017), 15, Seite 2378-2390","year":"2017","issue":"15"}}],"id":{"eki":["1580942814"],"doi":["10.1002/sim.7294"]},"recId":"1580942814","name":{"displayForm":["Heiko Götte, Marietta Kirchner, Martin Oliver Sailer, Meinhard Kieser"]},"physDesc":[{"extent":"13 S."}]} 
SRT |a GOETTEHEIKSIMULATION2420